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Neuronal drebrin A directly interacts with mDia2 
formin to inhibit actin assembly
ABSTRACT Dendritic spines (DS) are actin-rich postsynaptic terminals of neurons that are 
critical for higher-order brain functions. Maturation of DS is accompanied by a change in actin 
architecture from linear to branched filamentous structures. Presumably, the underlying cause 
of this is a switch in a mode of actin assembly from formin-driven to Arp2/3-mediated via an 
undefined mechanism. Here we present data suggesting that neuron-specific actin-binding 
drebrin A may be a part of such a switch. It is well documented that DS are highly enriched 
in drebrin A, which is critical for their plasticity and function. At the same time, mDia2 is 
known to mediate the formation of filopodia-type (immature) spines. We found that neuronal 
drebrin A directly interacts with mDia2 formin. Drebrin inhibits formin-mediated nucleation 
of actin and abolishes mDia2-induced actin bundling. Using truncated protein constructs we 
identified the domain requirements for drebrin–mDia2 interaction. We hypothesize that 
accumulation of drebrin A in DS (that coincides with spine maturation) leads to inhibition of 
mDia2-driven actin polymerization and, therefore, may contribute to a change in actin 
architecture from linear to branched filaments.
INTRODUCTION
Continuous assembly, disassembly, and reorganization of actin cyto-
skeleton is necessary for proper cell shape and function. For exam-
ple, in neurons, actin remodeling in dendritic spines (DS) and axonal 
growth cones is essential for synaptic plasticity and connectivity 
(Bertling and Hotulainen, 2017). Stability and dynamics of actin cy-
toskeleton are regulated by a large number of accessory proteins, 
and understanding their interplay in different cellular contexts pres-
ents a great challenge (Rottner et al., 2017).
Formins are actin nucleating and elongating factors that play 
important roles in many cellular processes (Chesarone et al., 2010; 
Breitsprecher and Goode, 2013). Some of the formins can also bind 
microtubules and actin filaments’ sides, further contributing to the 
regulation of cytoskeletal dynamics (Gaillard et al., 2011). On a 
structural level, the functional form of formins is an antiparallel di-
mer (Shimada et al., 2004; Xu et al., 2004) that stabilizes transient 
actin dimers and trimers, aiding F-actin nucleation. Formins are also 
processive actin-elongating factors that tightly associate with the 
barbed ends (B-ends) of filaments (Pruyne et al., 2002; Kovar et al., 
2006). Most often, formin-assisted actin polymerization is acceler-
ated in the presence of profilin–actin complexes (physiological state 
of monomeric actin) compared with G-actin alone (Sagot et al., 
2002). This effect is due to the presence of poly-proline motifs within 
FH1 domains of formins that serve as “traps” for profilin–actin com-
plexes, increasing their local concentration near filaments B-ends 
(Courtemanche and Pollard, 2012). Thus, under physiological 
conditions, formins assist actin elongation through FH1-dependent 
G-actin–profilin transfer while processively moving with growing B-
ends of actin filaments.
Owing to their potent effect on actin assembly, formins are most 
often autoinhibited in vivo (Watanabe et al., 1999; Alberts, 2001). 
Autoinhibition in different formins can be released by GTPases, 
often in conjunction with phosphorylation or other regulatory mech-
anisms (Kühn and Geyer, 2014). How fully activated formins are 
regulated in different cell types remains an open question. Available 
data suggest that formin-mediated actin nucleation and the 




Received: Oct 15, 2018
Revised: Dec 26, 2018
Accepted: Jan 3, 2019
This article was published online ahead of print in MBoC in Press (http://www 
.molbiolcell.org/cgi/doi/10.1091/mbc.E18-10-0639) on January 9, 2019.
†These authors contributed equally to this work.
‡Present address: Department of Chemistry and Biochemistry, California State 
University Long Beach, Long Beach, CA 90840.
*Address correspondence to: Emil Reisler (reisler@mbi.ucla.edu).
© 2019 Ginosyan, Grintsevich, and Reisler. This article is distributed by The 
American Society for Cell Biology under license from the author(s). Two months 
after publication it is available to the public under an Attribution–Noncommercial–
Share Alike 3.0 Unported Creative Commons License (http://creativecommons 
.org/licenses/by-nc-sa/3.0).
“ASCB®,” “The American Society for Cell Biology®,” and “Molecular Biology of 
the Cell®” are registered trademarks of The American Society for Cell Biology.
Abbreviations used: DS, dendritic spines; B-ends, barbed ends of actin filaments; 
F-actin, filamentous actin; G-actin, monomeric actin; IC50, concentration that 
yields half-maximum inhibition; TIRF, total internal reflection fluorescence.
Anush A. Ginosyana,†, Elena E. Grintsevicha,†,‡, and Emil Reislera,b,*
aDepartment of Chemistry and Biochemistry and bMolecular Biology Institute, University of California, Los Angeles, 
Los Angeles, CA 90095
Volume 30 March 1, 2019 Drebrin A inhibits mDia2 formin | 647 
yield diverse actin structures. It has been reported that protein regu-
lators such as Bud6, CLIP170, Adenomateous polyposis coli protein, 
and some tropomyosins can aid formin-mediated actin nucleation 
(Chesarone et al., 2010; Breitsprecher and Goode, 2013; Alioto 
et al., 2016). In contrast to that, only a few regulators that attenuate 
formins activity toward actin have been identified to date. The 
ubiquitous actin regulators such as profilin and capping protein are 
known to inhibit formin-mediated nucleation and elongation, re-
spectively (Paul and Pollard, 2008; Shekhar et al., 2016). Spire, which 
is an actin nucleating protein, works together with Capu formin in 
vivo, but inhibits its activity toward actin in vitro (Quinlan et al., 2007; 
Quinlan, 2013; Montaville et al., 2014). Formins are inhibited also by 
Hof1, Smy1, and Bud14 that function in yeast (Chesarone et al., 
2009; Chesarone-Cataldo et al., 2011; Graziano et al., 2014). How-
ever, our understanding of how formins’ activities are regulated in 
mammalian, and especially neuronal cells, is highly incomplete.
Formins emerged as an important class of regulators that are 
important in neuronal development and function. It was docu-
mented that formins are involved in shaping axonal growth cones 
(DAAM) (Matusek et al., 2008; Gombos et al., 2015), dendritic spine 
development (mDia2) (Hotulainen et al., 2009), and expansion 
(FMNL2) (Chazeau et al., 2014), as well as in linking receptors to the 
actin cytoskeleton (delphilin) (Miyagi et al., 2002). In line with the 
critical importance of formins in neuronal function, heterozygous 
deletion of the gene encoding formin 2 leads to intellectual disabil-
ity in humans (Almuqbil et al., 2013). However, how formins’ activi-
ties are incorporated with those of other neuronal actin regulators is 
not well understood.
In DS, actin-rich postsynaptic terminals of neurons, formins must 
exert their function in the presence of a high concentration of dre-
brin, which is one of the key actin regulators in DS (Koganezawa 
et al., 2017). Drebrin is an actin-stabilizing protein that alters the 
morphology of actin filaments and attenuates their severing by 
cofilin (Sharma et al., 2011; Mikati et al., 2013; Grintsevich and 
Reisler, 2014). Drebrin loss is reportedly associated with impaired 
higher-order brain functions, and it is a hallmark of Alzheimer’s 
disease and some other complex neurodegenerative disorders 
(Shim and Lubec, 2002; Ivanov et al., 2009; Ma et al., 2015). Thus, 
both formins and drebrin are critical for neuronal function and their 
missregulation is linked to brain disease. However, how drebrin and 
formins affect each other’s activities is unknown. To address this 
question, we investigated the effect of brain-specific drebrin A on 
actin assembly and remodeling by diaphanous formin 2 (mDia2).
RESULTS
Drebrin A inhibits mDia2-driven actin assembly
To bypass an autoinhibition of mDia2 formin, we employed its trun-
cated construct that is missing the N-terminal part of the sequence 
(seq. 1–520) and contains only FH1, FH2, and the C-terminal tail 
(mDia2-FFC, seq. 521–1171) (Li and Higgs, 2005). As expected, 
mDia2-FFC greatly accelerated the rate of actin polymerization 
compared with actin alone (Supplemental Figure S1, compare green 
and black traces). Next, we examined the effects of full-length neu-
ronal drebrin A (DrbA-FL; Figure 1A) on mDia2-driven actin polym-
erization using a standard bulk pyrene fluorescence assay. We found 
strong inhibition of actin polymerization by drebrin in the absence 
(Figure 1, B and C) and in the presence (Figure 1, D and E) of profilin. 
Drebrin-induced inhibition of mDia2-driven actin polymerization 
was concentration-dependent. The dependencies of polymeriza-
tion rates on drebrin concentration yielded IC50 of 40 and 70 nM, 
(with and without profilin, respectively). Next, we tested the C-termi-
nal truncated form of drebrin (Drb1–300; Figure 1F) that has affinity 
to F-actin, similar to that of DrbA-FL, and induces the same morpho-
logical changes in actin filaments (increased length of helical 
repeats) (Sharma et al., 2012). This drebrin construct (previously 
defined as the actin-binding core of drebrin, sequence 1–300) also 
inhibited mDia2-driven actin polymerization, but at least one order 
of magnitude weaker than DrbA-FL (Figure 1, G and H). The inhibi-
tory effect of Drb1–300 was also concentration-dependent (Figure 
1G) and was observed both in the absence and in the presence of 
profilin. The dependency of mDia2-driven actin polymerization 
rates on Drb1–300 concentration yielded IC50 close to 1 µM. It is 
important to note that the extent of inhibition of formin-driven actin 
assembly is lower with Drb1–300 construct than with DrbA-FL.
Next, we set out to determine which aspect(s) of formin-driven 
actin polymerization is (are) affected by drebrin. The increased lag 
phase in actin polymerization observed in our pyrene fluorescence 
assays (Figure 1, B, D, and G) suggested inhibition of mDia2-driven 
actin nucleation by drebrin A. To determine the effect of drebrin on 
mDia2-driven actin nucleation, we used direct total internal reflec-
tion fluorescence (TIRF) microscopy observation. We incubated 
actin (15% Alexa488SE-labeled on lysines), profilin, and formin with 
and without drebrin constructs for 10 min and then imaged the 
resulting mixtures on a polylysine-coated surface. We observed a 
reduction in the number of filaments formed in the presence of 
DrbA-FL compared with the control (Figure 2, compare A and B). At 
the same concentration, Drb1–300 also inhibited actin nucleation 
but to a significantly (P = 0.007, unpaired Student’s t test) smaller 
extent (Figure 2, compare B and C). Thus, drebrin inhibits mDia2 
formin-mediated actin nucleation.
Drebrin effects on actin elongation in the absence of formin
To further clarify the effects of drebrin on mDia2-driven actin poly-
merization, we assessed drebrin’s effect on the processive actin 
elongation by mDia2 in time-lapse single-filament TIRF assays.
First, we set out to determine whether neuronal drebrin A has any 
effects on elongation of actin filaments in the absence of mDia2 for-
min. Intriguingly, our single-filament TIRF microscopy assays revealed 
a previously undocumented effect of DrbA-FL on F-actin dynamics. 
We found that DrbA-FL inhibits F-actin elongation (Supplemental 
Figure S2A). We also found, that this inhibitory effect of DrbA-FL on 
F-actin elongation is preserved in the presence of profilin (Figure 2D, 
left panel, compare green and red dots). Specifically, the rate of fila-
ment elongation with profilin–actin complexes decreased approxi-
mately twofold (from 4.3 ± 0.7 subunits/s [n = 45] to 2.3 ± 0.5 
subunits/s [n = 19] for 0.5 µM actin). This suggests that neuronal dre-
brin A is a leaky capper of actin filaments that allows addition of actin 
monomers to growing ends but slows the rate of this process.
To clarify whether the observed inhibitory effect of DrbA-FL on 
actin elongation is due to the drebrin-induced morphological 
changes in actin filaments, we employed Drb1–300, which induces 
the same morphological changes in F-actin as DrbA-FL (Sharma 
et al., 2011, 2012). Interestingly, Drb1–300 construct did not show 
inhibition of actin filament elongation in time-lapse TIRF assays 
when used at the same concentration as DrbA-FL (Figure 2D, left 
panel, compare green and blue dots). We also tested a higher con-
centration of Drb1–300 (1.4 µM). Based on previously determined 
Kd values and stoichiometries, this concentration yields the same 
occupancy on actin as 0.7 µM of DrbA-FL (Ishikawa et al., 1994; 
Grintsevich et al., 2010; Sharma et al., 2011). Again, we did not 
observe any inhibition of actin elongation with Drb1–300. Further-
more, in both independent experiments described above, actin 
elongation rates in Drb1–300 containing samples were (on average) 
slightly higher (∼15%) than the corresponding controls (actin-profilin 
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FIGURE 1: Neuronal drebrin A inhibits mDia2-FFC-mediated actin assembly in a concentration-dependent manner. 
(A) Domain structure of DrbA-FL. Actin Depolymerizing Factor homology domain (ADFhd) is shown in green; helical-
charged domain is shown in orange; Actin Binding Domain (ABD) is shown in blue; intrinsically disordered C-terminal 
region is shown as a solid black line. The amino acid numbering is based on mouse drebrin isoform A (UniProtKB: 
Q9QXS6; methionine-1 was not present in the protein sequence). (B) DrbA-FL strongly inhibits mDia2-FFC-mediated 
actin assembly. mDia2-FFC drives rapid assembly of actin (1 µM) in the absence of DrbA-FL (black trace). DrbA-FL 
inhibits mDia2–FFC-driven actin assembly in a concentration-dependent manner (dark-blue to light-blue traces; 0.05, 
0.1, 0.15, 0.2, 0.25, 0.3, 0.4, 0.5, 0.6, and 0.7 µM DrbA-FL, respectively). (C) Quantification of the data shown in B. The 
concentration of DrbA-FL yielding half-maximum inhibition (IC50) of mDia2-FFC-mediated actin assembly is 70 nM. 
(D) DrbA-FL inhibits mDia2-FFC-mediated actin (1 µM) assembly in the presence of profilin (5 µM). The concentrations of 
DrbA-FL used were the same as in B. (E) Quantification of the data shown in D. The concentration of DrbA-FL yielding 
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samples) assayed on the same day with the same set of reagents 
(Figure 2D, left panel, compare green and blue dots). Thus, DrbA-FL 
but not Drb1–300 inhibit actin elongation from profilin–actin 
complexes.
To confirm that drebrin impacts the B-ends of actin filaments, we 
carried out annealing experiments (Supplemental Figure 2SB). We 
observed that filament annealing was greatly inhibited in the 
presence of DrbA-FL and much less with Drb1–300. This result is 
consistent with DrbA-FL inhibition of B-end elongation. Together, 
our results reveal that drebrin is a leaky capper of actin filaments and 
this activity depends on the intrinsically disordered C-terminal re-
gion of drebrin that is missing in the Drb1–300 construct.
Drebrin effect on actin elongation in the presence of 
mDia2 formin
Next, we hypothesized that the ability of drebrin to interfere with 
B-ends of actin filaments may have an effect on formin-mediated 
processive elongation of F-actin. We tested this hypothesis in time-
lapse single-filament TIRF assays (see Supplemental Movies S1–S3). 
In the presence of profilin–actin and mDia2-FFC, we expect two 
main populations of actin filaments—elongating fast (formin-bound, 
predominant population) and slowly (formin-free). In the presence 
of DrbA-FL we observed greater heterogeneity in elongation rates 
of actin filaments nucleated by mDia2-FFC from profilin–actin com-
plexes (Figure 2D, right panel, and Supplemental Figure S3). Actin 
filaments that were switching their elongation rates within the ob-
servation time (Figure 2E, bottom panel) were also included in the 
analysis, and therefore, infrequently, some of the filaments yielded 
more than one elongation rate (event; see examples in Supplemen-
tal Figure S3). When two phases of elongation were observed within 
the same filament (Supplemental Figure S3), their rates were not 
averaged but treated as two separate elongation events.
As expected, in the “mDia2-FFC only” sample (Figure 2D, right 
panel, green dots) we detected two populations of F-actin-elongat-
ing events—fast (main, formin-bound population, n = 21 events) 
and slow (minor, formin-free population, n = 3). Therefore, we used 
these values to define the fast and slow populations of actin- 
elongating events in drebrin-containing samples (Figure 2E and its 
legend). We defined fast elongation events in all three samples as 
those with elongation rates within mean ± 2 SD (Figure 2D, right 
panel, green dots) of the fast population in “mDia2-FFC only” 
(Figure 2E, white segments of the bars). Relative population sizes of 
the fast and slow actin elongation events are shown in Figure 2E. 
Comparison of mDia2-driven processive elongation of F-actin in the 
absence and presence of drebrin constructs revealed that even 
at saturating concentrations of DrbA-FL, a fraction of filaments 
exhibited rates similar to those observed in drebrin-free samples 
(17.4 ± 2.6 subunits/s [n = 16 events] vs. 17.3 ± 2.7 subunits/s [n = 21 
events], respectively). The samples containing drebrin constructs ex-
hibited several differences compared with the drebrin-free samples. 
First, the fraction of slow F-actin elongation events was greater than 
in the drebrin-free samples (Figure 2E, gray parts of the bars). This 
effect was most pronounced in the presence of DrbA-FL (50% of 
events exhibited slow or intermediate actin elongation rates). Sec-
ond, with DrbA-FL, we observed two populations of slow elongat-
ing F-actin. Specifically, some of these filaments grew at rates similar 
to those observed in the absence of formin, probably due to mDia2 
displacement from the B-ends (compare Figure 2D, red dots in the 
right and left panels). At the same time, we also observed a fraction 
of filaments that were elongating at slower rates (encircled in Figure 
2D, right panel) than those in the “actin-profilin–DrbA-FL” sample 
(Figure 2D, left panel). Therefore, we speculate that DrbA-FL may 
form an inhibitory complex with formin at the B-end, attenuating 
mDia2-driven F-actin elongation. Thus, drebrin A inhibits formin-
driven nucleation of actin and decreases the fraction of filaments 
growing at the rates characteristic of mDia2-driven processive elon-
gation compared with a drebrin-free control.
Domain requirements for inhibition of mDia2-driven actin 
assembly by drebrin
We set out to determine the domain requirements for the observed 
inhibition of mDia2 by drebrin. To this end, we employed C-terminal 
truncations of drebrin and mDia2 formin constructs. Structurally, the 
dimeric FH2 domain of formins is necessary and sufficient for actin 
nucleation (Sagot et al., 2002). However, it was recently shown that 
C-terminal regions of formins (tails) aid actin nucleation and improve 
the processivity of formins (Chhabra and Higgs, 2006; Vizcarra et al., 
2014). Notably, formins’ tails are considered a “hot spot” for interac-
tions with other proteins (such as Spire, tubulin, tumor suppressor 
adenomatous polyposis coli protein, and Bud6) (Pechlivanis et al., 
2009; Gaillard et al., 2011; Vizcarra et al., 2011; Breitsprecher et al., 
2012; Tu et al., 2012). Therefore, we employed mDia2, with and 
without its C-terminal tail (mDia2-FFC and mDia2-FF constructs), to 
test for a possible modulation of its function by drebrin.
We used pyrene fluorescence assays to assess the extent of 
mDia2-FFC and mDia2-FF formin inhibition by DrbA-FL and Drb1–
300 constructs (Figure 3). We used concentrations of drebrin con-
structs sixfold to ninefold higher than their IC50 values (Figure 1) to 
saturate the effect. We observed that DrbA-FL (0.25 µM) inhibits actin 
polymerization driven by mDia2-FFC to a greater extent than Drb1–
300 construct at 7 µM (Figure 3A and Supplemental Figure S4). This 
is consistent with the presence of a second mDia2-binding site in the 
C-terminal part of drebrin sequence (amino acids 301–706). Trunca-
tion of C-terminal “tail” region of mDia2-FFC (mDia2-FF construct) 
completely abolished inhibition by Drb1–300 in profilin-free samples 
(Figure 3B). It should be noted that in the presence of profilin, some 
inhibition of mDia2-FF-mediated actin assembly was observed with 
saturating concentrations of Drb1–300 (Supplemental Figure S4). We 
speculate that high concentrations of Drb1–300 (7 µM) may affect the 
processivity of formin, which would explain some inhibition of mDia2-
FF in the presence of profilin. This is in line with our single-filament 
TIRF microscopy assays revealing a greater fraction of slow actin elon-
gation events in the presence of Drb1–300 construct compared with 
a no-drebrin control (Figure 2E). At the same time, inhibition of 
mDia2-FF-mediated actin assembly by DrbA-FL was greatly weak-
ened, but still observed at all concentrations tested (0.25–1 µM) 
(Figure 3B, Supplemental Figure S4B, and unpublished data). The 
results of our bulk polymerization assays suggest that drebrin may 
half-maximum inhibition (IC50) of mDia2-FFC-mediated actin assembly is 40 nM. (F) Domain structure of Drb1–300. The 
disordered C-terminal region of drebrin has been truncated. (G) The rates of mDia2-FFC-mediated actin assembly 
decrease as Drb1–300 concentration is increased (black trace: no drebrin added; dark blue to light blue: 0.45, 0.7. 2, 4, 
5, 6, 8, and 10 µM Drb1–300, respectively). (H) Quantification of data shown in G. Drb1–300 concentration yielding 
half-maximum inhibition (IC50) of mDia2-FFC-mediated actin assembly is 810 nM. Conditions: [Actin] = 1 µM (10% 
pyrene-maleimide labeled); mDia2-FFC = 30 nM (B, C, D, E, F, and H). Additionally, 5 µM profilin was present in D and E. 
Buffer: KMEH7 (see Materials and Methods).
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FIGURE 2: Effects of drebrin on actin nucleation and elongations assessed in TIRF microscopy assays. 
(A–C) Representative images showing drebrin inhibition of mDia2-mediated nucleation of profilin–actin complexes. 
Actin polymerization (15% Alexa488SE-labeled) was started by the addition of polymerizing salts and the indicated 
proteins. After 10 min, F-actin was diluted with imaging buffer and immobilized on polyK-treated coverslip. 
Representative fields are shown. Conditions: [Actin] = 2 µM; [Profilin] = 10 µM; mDia2-FFC = 30 nM; [DrbA-FL] or 
[Drb1–300] = 0.7 µM. (D) Rates of actin filaments elongation determined from time-lapse TIRF microscopy experiments 
in the absence and presence of drebrin constructs. Left panel: without formin; Right panel: in the presence of mDia2-
FFC formin construct. The rates that are not representative of the mDia2-driven actin assembly are under the dashed 
line (bottom-right panel). Actin filaments that were elongating at slower rates than those in the “actin-profilin-DrbA-FL” 
sample are encircled (right panel). Conditions: [Actin] = 0.5 µM; [profilin] = 2.5 µM; [mDia2-FFC] = 1.5–3 nM; [DrbA-FL] or 
[Drb1–300] = 0.7 µM. (E) Population size of fast and slow F-actin elongation events observed in the samples (graphic 
representation of data in D, right panel). We used “FFC only” control (D, right panel, green dots) to define the fast 
population. In this sample, two populations of elongating filaments are evident: main (fast, n = 21 events) and minor 
(slow, n = 3 events) populations. The mean rate of the fast population in “FFC only” samples was 17.3 ± 2.7 subunits/s 
(n = 21 events). We defined fast elongation events in all three samples as those with elongation rates = mean ± 2 SD of 
the fast population in “FFC only” samples (white part of the bar). Populations of slow and intermediate elongating 
events are represented by a gray part of the bar. Note that we observed an increase in population size of slow 
elongating filaments with both DrbA-FL and Drb1–300. The numbers of filaments switching their elongation rates within 
observation time are shown for all samples in the bottom panel. Rare instances of filaments capped by photo-induced 
actin dimers (depolymerizing under our conditions) were excluded from the analysis.
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drebrin interaction with formin tail alone was 
weak (Figure 4, B and C). Sub-stoichiometric 
amounts of DrbA-FL were pulled down with 
GST-mDia2-tails, which is consistent with a 
weak interaction between drebrin and the 
mDia2 tail region (Figure 4B). We also tested 
the binding of Drb1–300 to GST-mDia2-tail 
in pull-down experiments. To aid in protein 
detection, we employed a Drb1–300-KCK 
construct labeled with Cy3 fluorescent dye. 
Incubation of 2 µM of GST-mDia2-tail with 1 
µM of Drb1–300-KCK-Cy3 revealed weak 
interaction between these two constructs 
that was detected via Cy3 fluorescence 
(Figure 4C). Thus, mDia2 and neuronal 
DrbA-FL interact directly through two inde-
pendent binding sites. Based on our data, 
the strong drebrin binding site is located in 
the FH2 domain of formin and it likely inter-
acts with the disordered C-terminal region 
of drebrin. The second (weak) drebrin bind-
ing site is located in the tail region of mDia2. 
Taken together, our data suggest that dre-
brin interaction with two sites on formin is 
required for strong inhibition of actin assem-
bly (see Discussion).
Full-length drebrin A inhibits F-actin 
bundling by mDia2-FH2
To better understand the functional conse-
quences of DrbA-FL binding to the FH2 do-
main of mDia2, we employed cosedimenta-
tion assays. It was documented earlier that 
mDia2 formin has actin side-binding activity. 
This activity leads to a formation of F-actin 
bundles and is mediated by the mDia-FH2 
domain (Harris et al., 2006). In light of a direct interaction of drebrin 
with the FH2 domain of formin, we hypothesized that DrbA-FL (but 
not Drb1–300) may affect actin filaments bundling by mDia2. Our 
low-speed centrifugation assays confirmed this hypothesis. Specifi-
cally, DrbA-FL abolished F-actin bundling by mDia2 in a concentra-
tion-dependent manner (Figure 5, A and B). The effect of Drb1–300 
construct on actin bundling by mDia2-FH2 was dramatically weak-
ened compared with that of the DrbA-FL (Figure 5, C and D).
We wished to gain more insight into debrin-induced inhibition of 
mDia2-FH2-mediated bundling. Under our experimental conditions, 
F-actin bundling was not detected with any of the drebrin constructs 
tested by low-speed cosedimentation (Figure 5C, lanes 3–6). How-
ever, our TIRF assays show that Drb1–300 can lightly bundle F-actin. 
Such activity of a similar drebrin construct was reported previously 
(Worth et al., 2013). It was predicted that a deletion of C-terminal 
sequence of drebrin (as well as phosphorylation at S142) exposes an 
actin binding site (which is otherwise masked by the C-terminus of 
drebrin) and allows for bundling. We were concerned that different 
effects of DrbA-FL versus Drb1–300 constructs (on actin bundling by 
mDia2-FH2) may arise from the differences in their own actin bun-
dling properties. Therefore, we employed a phosphomimetic mutant 
of drebrin (DrbA-FL-S142D) that was shown to induce F-actin 
bundling similar to the Drb1–300 construct (Worth et al., 2013). 
We set out to determine whether DrbA-FL-S142D would inhibit 
mDia2-FH2–induced actin bundling in the same manner as unphos-
phorylated drebrin. We found that similar to DrbA-FL, its S142D 
FIGURE 3: Domain requirements for drebrin-induced inhibition of mDia2-driven actin assembly. 
Graphic representations of proteins present in the reactions (except for drebrin constructs) are 
shown in each panel. The FH1, FH2, and C-terminal tail domains of mDia2 are shown in blue, 
gray, and orange, respectively. Green spheres represent actin. Each panel demonstrates the 
effects of DrbA-FL and Drb1–300 on the rates of actin assembly by mDia2-FFC (A) or its 
C-terminal tail missing version, mDia2-FF (B) (shown as an orange line in the schematics). In each 
panel (A, B) white, gray, and black bars represent actin assembly rates when no drebrin, 
DrbA-FL, or Drb1–300, respectively, are added. (A) Actin assembly mediated by mDia2-FFC is 
inhibited strongly in the presence of DrbA-FL. This inhibition is weaker in the presence of 
Drb1–300. (B) Actin assembly mediated by mDia2-FF is partially inhibited in the presence of 
DrbA-FL but not in the presence of Drb1–300. Note that the error bar in the no-drebrin 
condition is too small to be visible. Representative sets of data are shown. Error bars mean ± SD 
(n = 3 replicates). Conditions: [Actin] = 1 µM (10% pyrene-maleimide); [mDia2-FFC] = 30 nM; 
[DrbA-FL] = 0.25 µM; [Drb1–300] = 7 µM. Buffer: KMEH7.
have two binding sites on formin—one within the formin’s tail region 
and another one in the FH1-FH2 sequence.
Drebrin is a novel binding partner of mDia2
We used pull-down assays to probe for direct interaction between 
mDia2 and drebrin. The FH2 domain and C-terminal tail region of 
formins are largely responsible for accelerated actin nucleation and 
formin’s processivity (Sagot et al., 2002; Pring et al., 2003; Vizcarra 
et al., 2014). Drebrin binding to one or both of these regions would 
be consistent with its inhibition of formin-mediated actin assembly.
We first tested GST-drebrin interaction with FH2 domain of for-
min (tail region is truncated). Our data revealed complex formation 
between FH2 domain of mDia2 and DrbA-FL (Figure 4A). Specifi-
cally, incubation of 1 µM of GST-DrbA-FL with 2 µM of mDia2-FH2 
resulted in their complex formation with ∼1:1 binding stoichiometry 
(Figure 4A, lane 6). Each molar equivalent of GST-DrbA-FL bound 
0.92 ± 0.21 equivalents of mDia2-FH2 (n = 4 pull-down experiments; 
mean ± SD). The quantitative pull-down experiment yielded a Kd of 
∼0.7 µM for mDia2-FH2 binding to drebrin A (Supplemental Figure 
S5). In contrast to that, binding of Drb1–300 to mDia2-FH2 was 
weak at best (Supplemental Figure S6).
As shown in Figure 3B and Supplemental Figure S4B, the trunca-
tion of C-terminal tail of mDia2 weakened drebrin’s inhibition of 
mDia2-FF-driven actin assembly. Thus, we expected drebrin to bind 
strongly to C-terminal tails of mDia2 formin. However, our pull-
down experiments with DrbA-FL and Drb1–300 indicated that 
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FIGURE 4: Drebrin A is a novel binding partner of mDia2. (A) GST-
DrbA-FL directly binds mDia2-FH2. GST or GST-DrbA-FL (1 µM) was 
incubated with mDia2-FH2 (2 µM) at 4°C overnight (lanes 1–3, Input). 
These samples were applied to glutathione-Sepharose beads, 
incubated for 3 h at 4°C, and then eluted with a volume of 
glutathione, 1/10th of the input volume (lanes 4–6, Elution 10x). 
Samples were analyzed by SDS–PAGE and Coomassie Blue staining. 
Note that mDia2-FH2 does not significantly bind beads or GST alone 
(lanes 4 and 5, red-lined panel), but coelutes with GST-DrbA-FL (lane 
6, red-lined panel). Buffer: KMEH7, 0.5 mM Thesit, 0.05% IGEPAL CA 
630. (B) GST-mDia2-tail binds substoichiometric amounts of DrbA-FL. 
GST or GST-mDia2-tail (2 µM) was incubated with DrbA-FL (1 µM) and 
glutathione-Sepharose beads for 2 h at 4°C. Flow-through (FT, lanes 1 
and 2) and beads (lanes 3 and 4) were analyzed by SDS–PAGE and 
Coomassie Blue staining. Note that DrbA-FL binds GST-mDia2-tail 
(lane 4, red-lined panel) to a much greater extent than GST alone (lane 
3, red-lined panel). Buffer: KMEH7, 0.5 mM Thesit. (C) GST-mDia2-tail 
binds sub-stoichiometric amounts of Drb1–300KCK-Cy3. GST or 
GST-mDia2-tails (2 µM) were incubated with Cy3-labeled Drb1–300 
(1 µM) at 4°C overnight (lanes 1–3, Input). These samples were 
applied to glutathione-Sepharose beads, incubated for 3 h at 4°C, 
and then eluted with a volume of glutathione, 1/5th of the input 
volume (lanes 4–6, Elution 5×). Samples were analyzed by SDS–PAGE 
and then visualized using Cy3 fluorescence. Note that Drb1–300 
KCK-Cy3 binds very weakly to beads or GST alone (lanes 4 and 5), but 
coelutes with GST-mDia2-tail (lane 6). Buffer: KMEH7, 0.5 mM Thesit, 
0.05% IGEPAL CA 630.
phosphomimetic mutant abolishes F-actin bundling by mDia2-FH2 
(Figure 5E). This is in a good agreement with the evidence for direct 
interaction of drebrin with the FH2 domain of mDia2 formin.
Notably, high-speed centrifugation showed that mDia2-FH2 and 
DrbA-FL can cobind F-actin leading to a formation of a tertiary com-
plex (Figure 6A). We also found that DrbA-FL causes partial dis-
placement of mDia2-FH2 from actin filaments but Drb1–300 does 
not (Figure 6B). Therefore, we asked whether DrbA-FL inhibits 
mDia2-FH2–induced bundling by partially displacing it from actin 
filaments. We found that in the presence of DrbA-FL, the amount of 
mDia2-FH2 that was still bound to F-actin (∼0.5 µM) would be suffi-
cient to induce extensive bundling (Supplemental Figure S7). Spe-
cifically, in the presence of DrbA-FL, binding of 0.5 µM of mDia2-
FH2 to actin (Figure 6B) resulted in 2.8 ± 2.4% of bundled F-actin (in 
low-speed pellet, Figure 5D, middle bar). In contrast to that, 0.5 µM 
mDia2-FH2 added to bare F-actin yielded >70% bundling (see Sup-
plemental Figure S7B, red arrow). Thus, partial displacement of 
mDia2-FH2 by DrbA-FL cannot account for the observed dramatic 
inhibition of actin bundling.
High-speed centrifugation with Drb1–300 revealed its codecora-
tion of F-actin with mDia2-FH2, similar to that observed with DrbA-
FL. Because Drb1–300 did not show strong binding to mDia2-FH2 in 
pull-down assays, these results suggest that the N-terminal sequence 
of drebrin (Drb1–300) and mDia2-FH2 may occupy nonoverlapping 
binding sites on F-actin. Structural analysis of such complexes, which 
is beyond the scope of this study, is needed to test this prediction. 
Thus, our data are consistent with the possibility that inhibition of 
mDia2-induced actin bundling by drebrin A is mediated through its 
interaction with the FH2 domain of mDia2 formin.
DISCUSSION
In this study we documented that drebrin is a previously unknown 
inhibitor of actin assembly driven by mDia2. Additionally, we dem-
onstrated using single-filament TIRF microscopy assays that neuro-
nal drebrin A inhibits actin elongation in the absence of formins. We 
gained insights into the mechanism of drebrin’s inhibition of mDia2 
function by demonstrating a direct interaction between these two 
proteins in pull-down assays. Furthermore, we clarified the domain 
requirements for mDia2 inhibition by drebrin using their truncated 
constructs. On the basis of our data, we propose a model of dre-
brin–formin interaction in which FH2 domain of formin interacts with 
the intrinsically disordered C-terminal part of drebrin molecule. At 
the same time, our data suggest the presence of a second (weaker) 
drebrin-binding site in the C-terminal “tails” of mDia2 (see model in 
Figure 6C).
We documented that drebrin attenuates several aspects of actin 
dynamics in the absence and presence of mDia2 formin. First, we 
showed that drebrin inhibits actin nucleation. The results of our pull-
down experiments, TIRF microscopy and pyrene fluorescence as-
says suggest that drebrin’s association with both the C-terminal tail 
and FH2 domain of mDia2 contributes to this effect. This conclusion 
is based on the observations (Figure 2, A–C) that both DrbA-FL and 
Drb1–300 inhibit actin nucleation but to different extents. Specifi-
cally, full-length drebrin exhibits stronger inhibition of mDia2, 
consistent with the presence of an FH2 domain-binding site in its 
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FIGURE 5: Drebrin A inhibits bundling of filamentous actin by mDia2. (A) DrbA-FL inhibits mDia2–FH2-induced F-actin 
bundling in a concentration-dependent manner. Increasing amounts of DrbA-FL (0, 0.05, 0.15, 0.29, 0.50, and 1 µM) 
were added to mDia2-FH2 (0.8 µM) and F-actin (2 µM). Low-speed pellets were concentrated twofold to aid in protein 
quantification. Note that as DrbA-FL concentration increases, the amount of actin in the low-speed pellet decreases 
(lanes denoted with asterisks, red box), whereas the amount of actin in the supernatant increases. (B) Amounts of 
F-actin bundled by mDia2-FH2 in the presence of DrbA-FL. Quantification of the data shown in the red box panel of 
A (in lanes marked with asterisk). (C) C-terminal truncation of drebrin sequence dramatically reduces its inhibitory effect 
on mDia2–FH2-induced F-actin bundling. Either DrbA-FL (0.85–1 µM) or Drb1–300 (1.9 µM) was added to mDia2-FH2 
(0.8 µM) and phalloidin-stabilized F-actin (2 µM). Pellets were concentrated twofold to aid in quantification. Note that no 
bundling (actin in pellet) is detected with actin alone and both drebrin constructs (lanes 1–6, red panel). In the presence 
of mDia2-FH2 actin was found in the pellet (lane 7, red panel). DrbA-FL strongly inhibits mDia2-FH2-mediated bundling 
such that almost no actin was detected in the pellet (lane 9, red panel). However, Drb1–300 did not affect mDia2-FH2-
mediated bundling to any considerable extent (lane 11, red panel). (D) Quantification of the amounts of actin in 
low-speed pellets in the presence of mDia2-FH2 (FH2) and drebrin constructs. Representative gel is shown in C. Error 
bars: mean ± SD (n = 3 experiments). (E) Phosphomimetic mutant of drebrin A (DrbA-FL-S142D) inhibits mDia2-FH2 
F-actin bundling as well as DrbA-FL. DrbA-FL-S142D (1 µM) was added to mDia2-FH2 (0.8 µM) and F-actin (2 µM). 
Low-speed pellets were concentrated fourfold to aid in their quantification. Note that F-actin alone is not bundled (actin 
can be detected in the supernatant, lane 2). mDia2-FH2 bundles F-actin (actin can be detected in the pellet, lane 3, red 
panel). When DrbA-S142D is introduced, mDia2-FH2-mediated bundling of F-actin is inhibited (actin is mostly in the 
low-speed supernatant; compare lanes 7 and 8, red panel).
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(Figure 3) suggest that drebrin interaction 
with formin tails is largely responsible for the 
observed inhibition of mDia2-driven actin 
assembly.
We also documented that neuronal dre-
brin A inhibits actin elongation in the ab-
sence of formin. It is unlikely that this effect 
would be mediated via characteristic 
drebrin- induced morphological changes in 
actin filaments. We deduced this from our 
experiments with Drb1–300 construct that 
induces the same changes in F-actin mor-
phology as DrbA-FL (Sharma et al., 2012) 
but does not inhibit actin elongation (Figure 
2D, left panel). Thus, it is possible that intrin-
sically disordered C-terminal part of drebrin 
A can transiently interact with the B-end of 
actin filament and interfere with monomers 
addition. In vivo, such activity of debrin A 
may interfere with the binding of B-end in-
teracting proteins to actin filaments.
In the presence of mDia2 and drebrin 
constructs we observed a greater heteroge-
neity of single-filament elongation rates than 
in the no-drebrin control (Figure 2, D and E). 
We hypothesize that such increased hetero-
geneity may arise from several factors (or 
their combination). Because we observed a 
larger fraction of slow F-actin–elongating 
events with both full-length drebrin A and 
Drb1–300, it is possible that drebrin-induced 
changes in actin morphology may affect the 
duration of formin’s processive runs. Addi-
tionally, decoration of actin filaments by dre-
brin may bring its inhibitory sequence(s) into 
close proximity to barbed-end bound for-
min. Specifically, we observed a fraction of 
filaments elongating at slower rates (encir-
cled in Figure 2D, right panel) than those in 
the “actin-profilin-DrbA-FL” sample, which 
suggests a formation of an inhibitory com-
plex between drebrin (bound to F-actin) and 
formin at the B-end. The above factors (or 
their combination) may attenuate the pro-
cessivity of mDia2. It should be noted that it 
is unknown whether the drebrin sequence(s) 
that inhibit(s) mDia2 is/are also responsible 
for its leaky F-actin capping activity.
We also documented strong inhibition of actin bundling by 
mDia2-FH2 in the presence of drebrin A, but the physiological role 
of this inhibition is yet to be determined. Thus, the role of mDia2-
induced actin bundling in neuronal function and development is yet 
to be defined.
Several lines of evidence suggest that a cross-talk between dre-
brin and formins can be physiologically important for dendritic 
spine formation. It was previously documented that mDia2- 
induced actin nucleation/polymerization is critical for the develop-
ment and morphology of DS (Hotulainen et al., 2009). During DS 
development, filopodium-type protrusions (lacking spine heads) 
progress to the spine types that can support synaptic transmission 
and are usually composed of a neck and bulbous head. Hotulainen 
et al. (2009) proposed a model of actin remodeling during 
FIGURE 6: mDia2-FH2 and drebrin constructs codecorate F-actin. (A) High-speed 
sedimentation of DrbA-FL and Drb1–300 with F-actin and mDia2-FH2. DrbA-FL (0.85 µM) or 
Drb1–300 (1.9 µM) was added to mDia2-FH2 (0.8 µM) and F-actin (2 µM). Note that both 
mDia2-FH2 and drebrin constructs are detected in high-speed pellets, with the formin construct 
band just above the actin band (lanes 9 and 11). (B) DrbA-FL, unlike Drb1–300, partially displaces 
mDia2-FH2 (FH2) from F-actin. Quantification of data shown in A. Error bars: mean ± SD (n = 3 
experiments). (C) Proposed working model of mDia2–drebrin A interaction. FH1, FH2, and 
C-terminal tail of mDia2 formin are shown in dark blue (line), gray, and orange (line), respectively. 
The N-terminal sequence of drebrin is shown as a tricolored box, and the intrinsically disordered 
C-terminal part of drebrin is shown as a black line. Strong drebrin binding to mDia2 requires two 
interaction sites. High-affinity binding between the FH2 domain of formin and the C-terminal 
part of drebrin guides its interaction with the second interacting site within formin tails. Drebrin 
interaction with isolated mDia2-tails is weak but it is improved in mDia2-FFC construct due to 
the increase of local drebrin concentration near the formin’s tails.
C-terminal sequence (aa 301–706) in addition to that in the aa 1–300 
region (Figure 4). We also found that truncation of the tail region of 
mDia2 (mDia2-FF construct) dramatically reduces but does not 
abolish the inhibition of formin-driven actin assembly by DrbA-FL, 
which is consistent with the presence of a drebrin-binding site out-
side the mDia2-tail region (Figure 3B and Supplemental Figure 
S4B). We hypothesize that strong drebrin binding to formin requires 
two interaction sites (Figure 6C). Our data are consistent with the 
scenario in which high-affinity binding between FH2 domain of for-
min and the C-terminal part of drebrin guides its interaction with the 
second interacting site within formin tails. Therefore, drebrin inter-
action with isolated mDia2-tails is weak but it is improved in mDia2-
FFC construct due to the increase of local drebrin concentration 
near the formin’s tails. Experiments with mDia2-FF formin construct 
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dendritic spine development. Their model suggests that spine for-
mation starts with the initiation and elongation of dendritic filopo-
dium, where actin polymerization is driven by mDia2 formin local-
ized in the filopodium tip. Based on the loss of spine heads on 
overexpression of constitutively active mDia2, it was proposed 
that during spine head formation, the mechanism of actin assem-
bly changes from mDia2-driven (unbranched) to Arp2/3-mediated 
(branched), which is consistent with a critical role of Arp2/3 in 
spine head formation (Hotulainen et al., 2009). However, what trig-
gers such a change in actin architecture during DS development is 
unclear. Our results point toward the possible role of drebrin A in 
this process. We speculate that accumulation of drebrin A in DS, 
occurring during spine maturation, can lead to the inhibition of 
mDia2-driven actin polymerization. This may aid other actin regu-
lators in promoting actin branching. It is also important to note 
that, even at saturating concentrations of drebrin, we observed a 
fraction of formin-bound filaments that were elongating with rates 
similar to drebrin-free controls. This might be physiologically sig-
nificant for the reported formin-driven expansion of mature spines, 
where drebrin could limit formin-driven actin polymerization but 
does not block it completely—allowing for the formation of spike-
like protrusions in spine heads (Chazeau et al., 2014).
In conclusion, this study provides new insights into formin regu-
lation of actin assembly in neuronal cells and its interplay with 
drebrin.
MATERIALS AND METHODS
Protein expression, purification, and labeling
Rabbit skeletal actin (Spudich and Watt, 1971), profilin (Harris et al., 
2004), Drb1–300, and GST-Drb1–300 construct (Grintsevich et al., 
2010) were prepared as described previously. Actin was labeled with 
pyrene maleimide and Alexa488-SE using published protocols 
(Grintsevich et al., 2017). Drb1–300-KCK was labeled with Cy3 as 
previously described (Sharma et al., 2012; Grintsevich et al., 2017).
The mDia2-FFC (amino acids 521–1171, mouse) containing plas-
mid was a generous gift from H. Higgs (Dartmouth College). The 
mDia2-FF construct was created via mutagenesis, with primers de-
signed to introduce a stop codon after the FH2 domain (residue 
1034). The mDia2-FH2 construct (amino acids 612–1034, mouse) 
was a kind gift from M. Quinlan (UCLA). The mDia2-FFC, FF, and tail 
(seq. 1008–1171) constructs were expressed as N-terminal GST 
fusion constructs in Escherichia coli Rosetta2 cells (Li and Higgs, 
2003). Purification of the formin constructs was carried out essen-
tially as described (Li and Higgs, 2003), with the following modifica-
tions. Formin constructs were purified on a glutathione-Sepharose 
4B (GE Healthcare) column, and GST-tag was cleaved with thrombin 
overnight at 4°C. Cleaved formin constructs were further purified 
using gel-filtration on HiLoad 16/60 Superdex 75 (Amersham 
Biosciences).
DrbA-FL was expressed and purified as described (Sharma 
et al., 2011), with the following modifications. Before elution 
from the glutathione-Sepharose column, preparations were sub-
jected to a wash (50 ml total volume) with buffer A (20 mM 
HEPES, pH 7.4, 20 mM MgCl2, 5 mM ATP, 150 mM KCl, 0.1% 
IGEPAL CA 630) in addition to high-salt (1 M NaCl) and glycerol 
(10%) washes. Specifically, GST-drebrin–bound glutathione-Sep-
harose beads were incubated with 10 ml of buffer A for 25 min 
and then washed with the rest of buffer A. The wash with buffer 
A was found to be important for consistency of pyrene-actin 
polymerization assays in the presence of formin. After protein 
elution from the glutathione-Sepharose column and overnight 
dialysis at 4°C against drebrin prep buffer (21.4 mM Na2HPO4, 
3.8 mM KH2PO4, pH 7.5, 300 mM NaCl, and 5 mM β-
mercaptoethanol [β-ME]), GST-tag was cleaved with PreScission-
Protease for 2.5 h at 4°C. After the cleavage, DrbA-FL was loaded 
onto HisTrap column (1 ml) and treated with benzonaze for 15 
min at 4°C. Before elution, DrbA-FL was washed with buffer A 
without IGEPAL CA 630. Drebrin was eluted with the gradient 
(0–100%) of imidazole (10 mM Tris, pH 8, 300 mM NaCl, 5% glyc-
erol, 3 mM β-ME, and 0–250 mM imidazole). The final gel-filtra-
tion step was carried out on a HiLoad 16/60 Superdex 75 column 
(Amersham Biosciences). Drebrin was concentrated, dialyzed 
against the DDB buffer (5 mM Tris, 100 mM KCl, and 1 mM 
dithiothreitol [DTT]), and stored at –80°C. GST-DrbA-FL was 
purified using the same scheme except for the omission of the 
HisPur Cobalt gravity column, GST-tag cleavage step, and gel-
filtration. GST-DrbA-FL preparations contained a small fraction of 
C-terminally truncated GST-DrbA that could not be efficiently 
separated due to GST dimerization.
Actin polymerization assays
Mg-ATP G-actin (10% pyrene-maleimide labeled) was prepared by 
incubating Ca-ATP-G-actin with ME exchange buffer (0.05 mM 
MgCl2 and 0.2 mM ethylene glycol-bis(2-aminoethylether)-
N,N,N’,N’-tetraacetic acid [EGTA]) for 3 min. Actin polymerization 
was initiated immediately after Ca/Mg exchange by the simultane-
ous addition of polymerization buffer KMEH7 (50 mM KCl, 1 mM 
MgCl2, 1 mM EGTA, 10 mM HEPES, pH 7, 1 mM DTT, and 0.2 mM 
ATP) and actin-binding proteins (profilin, drebrin, and formin con-
structs). The average delay between the beginning of actin polym-
erizations and the first measurement was ∼35 s. Changes in pyrene 
fluorescence signal were monitored over time (1–4 h) using a micro-
plate-reading fluorimeter (TECAN). SigmaPlot software was used to 
fit actin polymerization kinetics to exponential expressions yielding 
polymerization rates and their standard deviations.
TIRF microscopy
To assess actin nucleation efficiency of mDia2 in the presence of 
drebrin constructs, we carried out the reactions, diluted them, and 
immobilized actin filaments on the polylysine-coated surface. Spe-
cifically, coverslips were treated with 1 mg/ml polylysine for 3 min, 
rinsed with mQ water, and air-dried. Mg-ATP-G-actin (2 µM 15% 
Alexa488-SE labeled) was polymerized in KMEH7 in the presence of 
profilin (10 µM) and mDia2-FFC (30 nM) with and without drebrin 
constructs (0.7 µM). After 10 min at room temperature, samples 
were diluted 67-fold in KMEH7, supplemented with 100 mM DTT 
and 1 µM phalloidin, and applied onto polyK-coated coverslips. 
Random fields were imaged using a DMI6000 TIRF microscope 
(Leica). Actin filaments were counted manually.
Time-lapse TIRF microscopy was performed as described (Gurel 
et al., 2014; Grintsevich et al., 2017). In brief, untethered actin fila-
ments were imaged on a Pluronic coated surface. Flow chambers (V 
∼12 µl) were treated with two chamber volumes (CV) of 1% Pluronic 
F127 solution (Sigma; P2443) for 3 min and then equilibrated with 
2 CV of 1× TIRF-imaging buffer (10 mM HEPES, 1 mM MgCl2, and 50 
mM KCl, 0.2 mM EGTA [pH 7] supplemented with 50 mM DTT, 0.2 
mM ATP, 20 mM glucose, and 0.5% methyl cellulose). G-actin–pro-
filin mixtures (0.5 µM 15% Alexa488-SE labeled actin, 2.5 µM human 
profilin-1) were incubated for 3 min at room temperature (RT) with 
ME exchange buffer. Then, Mg-ATP-G-actin in complex with profilin 
was mixed with polymerizing salts supplemented with mDia2FFC 
(1–3 nM), with and without drebrin constructs (0.7 µM). The resulting 
mixture (4 CV) was introduced into the flow chamber. Actin mixtures 
were supplemented with 0.05 mg/ml caseine, 0.25 mg/ml glucose 
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oxidase, and 50 µM catalase to minimize protein damage due to free 
radical formation and photobleaching during the imaging. Filaments 
were imaged using a DMI6000 TIRF microscope (Leica). Images were 
acquired every 10 s. All time-lapse TIRF data were analyzed using 
ImageJ (Fiji) software (National Institutes of Health, Bethesda, MD).
Pull-down assays
Pull-down experiments with GST-DrbA-FL or GST-mDia2-tail con-
structs were performed as follows. GST-tagged constructs or GST 
were incubated overnight at 4°C with untagged proteins of interest 
in IT-KMEH7 buffer (10 mM HEPES, pH 7, 1 mM EGTA, 1 mM 
MgCl2, 50 mM KCl, 1 mM DTT, 0.05% IGEPAL, 0.5 mM Thesit, and 
0.9–2.2 mM Tris, pH 8). The resulting samples (Inputs, Figure 4, A 
and C) were applied onto glutathione-Sepharose beads equili-
brated with IT-KMEH7 and nutated for 3 h at 4°C. Beads were 
pelleted using a bench-top centrifuge (max 2000 × g; ISC Bio-
Express minicentrifuge C-1301P) and then washed one time with 
five bead volumes of IT-KMEH7 (125 µl). Proteins were eluted with 
10 mM glutathione elution buffer (1/10th or 1/5th of input volumes 
for Figure 4, A and C, respectively).
Pull-down experiments with GST-mDia2-tails and untagged 
DrbA-FL (Figure 4B) were carried out essentially as described above 
with minor modifications. GST-tagged mDia2-tail or GST were incu-
bated with DrbA-FL for 10 min at 25°C in T-KMEH7 buffer (10 mM 
HEPES, pH 7, 1 mM EGTA, 1 mM MgCl2, 50 mM KCl, 1 mM DTT, 
and 0.5 mM Thesit). Samples were applied onto glutathione-Sepha-
rose beads (equilibrated with T-KMEH7) and nutated at 4°C for 2 h. 
Beads were precipitated by centrifugation (14,000 rpm [20,817 × g], 
2 min, 4°C). Beads were then washed three times with eight column 
volumes of T-KMEH7 (24 column volumes total). After washes, 
beads were pelleted by centrifugation and resuspended in one col-
umn volume of T-KMEH7. Supernatants and bead suspensions were 
supplemented with SDS–PAGE sample-loading buffer and boiled 
for 3 min.
All inputs and eluates were analyzed by SDS–PAGE. Drb1–
300-KCK-Cy3 was detected via Cy3 fluorescence. Gels were stained 
with Coomassie Blue. Quantification of the gels was done using 
ImageJ software.
High- and low-speed pelleting assays
For high-speed pelleting assay, Mg-ATP F-actin (5 µM) was prepared 
by incubating Ca-ATP-G-actin in ME buffer for 3 min, followed by 
overnight incubation in a polymerization buffer (10 mM HEPES, 
pH 7, 1 mM EGTA, 1 mM MgCl2, 50 mM KCl, 1.4–1.8 mM Tris, pH 8, 
1 mM DTT, and 0.2 mM ATP) at 4°C. Actin stock was then diluted to 
2 µM with KMEH7 (10 mM HEPES, pH 7, 1 mM EGTA, 1 mM MgCl2, 
and 50 mM KCl) in the presence or absence of mDia2-FH2 and dre-
brin constructs (at concentrations that would correspond to ≥80% 
occupancy on F-actin: [DrbA-FL] = 0.85 µM and [Drb1–300] = 
1.9 µM). Reaction mixtures were incubated at room temperature for 
10 min and then subjected to high-speed centrifugation (TLA100 
rotor, 80,000 rpm, 4°C, 20 min).
For low-speed pelleting experiments with mDia2-FH2, we fol-
lowed the established protocol (Harris et al., 2006). To pellet F-actin 
bundles, protein mixtures were incubated at room temperature for 
1 h and then subjected to low-speed centrifugation (16,000 × g, 
4°C, 5 min) (Harris et al., 2006). For some of these assays, F-actin 
was stabilized with phalloidin (1:1 M ratio), as indicated in the figure 
legends.
High- and low-speed supernatants and pellets were analyzed by 
SDS–PAGE. Gels were stained with Coomassie Blue. ImageJ soft-
ware was used to determine the intensities of the gel bands.
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